0001415889-22-004958.txt : 20220513
0001415889-22-004958.hdr.sgml : 20220513
20220513164208
ACCESSION NUMBER: 0001415889-22-004958
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220511
FILED AS OF DATE: 20220513
DATE AS OF CHANGE: 20220513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Payson Norman
CENTRAL INDEX KEY: 0000898544
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 22923478
MAIL ADDRESS:
STREET 1: 800 N. GLEBE ROAD, SUITE 500
CITY: ARLINGTON
STATE: VA
ZIP: 22203
FORMER NAME:
FORMER CONFORMED NAME: PAYSON NORMAN C MD
DATE OF NAME CHANGE: 19930310
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
form4-05132022_010509.xml
X0306
4
2022-05-11
0001551306
Progyny, Inc.
PGNY
0000898544
Payson Norman
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL
NEW YORK
NY
10018
true
false
false
false
Common Stock
2022-05-11
4
S
0
5518
33.30
D
491928
I
See footnote
Common Stock
2022-05-11
4
S
0
1100
34.18
D
490828
I
See footnote
Common Stock
2022-05-12
4
S
0
5305
33.13
D
485523
I
See footnote
Common Stock
2022-05-12
4
S
0
1313
33.89
D
484210
I
See footnote
Common Stock
122493
I
See footnote
Common Stock
8652
D
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on March 9, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.925 to $33.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
The reportable securities are directly held by Norman C. Payson and Melinda B. Payson, Trustees of The Norman C. and Melinda B. Payson Revocable Trust.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.93 to $34.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 to $33.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.585 to $34.42, inclusive. The Reporting P erson undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth.
The reportable securities are directly held by EVO Eagle, LLC. The Reporting Person shares voting and dispositive power over the securities.
/s/ Jennifer Bealer, Attorney-in-Fact
2022-05-13